Regarding HCC risk in patients with CHB who are being treated with potent antivirals, a few studies showed that early ALT normalization with antiviral agent treatment has a lower risk of developing liver-related events in patients with chronic HBV [12]. This evidence concerns the gene GPT and hepatocellular carcinoma.